Ochsner Ventures

Ochsner Ventures

Ochsner Clinic Foundation Retirement Plan began in 1957 as a private-sector defined benefit plan. Aimee Quirk serves as CEO of its venture arm while holding the role of SVP at Ochsner Health. The structure channels pension assets into healthcare innovation alongside the foundation's clinical operations. Allocations include private equity exposure at 13.06 percent alongside venture commitments. Confirmed holdings comprise South Rampart Pharma, Clarapath, SafeSource Direct, Nest Health, myLaurel, Obatala Sciences, Hippo Technologies, Sound Health Systems, Judi Health, and CoachCare. Activity centers on the United States with emphasis on Louisiana and Gulf South markets. The plan also maintains positions in Vanguard Total Stock Market ETF and Ochsner Clinic Foundation Series 2016 Bonds. The team maintains relationships with Louisiana Economic Development through the $10 million Ochsner Louisiana Innovation Fund. Additional offices are not disclosed. Service providers include Jones Walker LLP for legal counsel and FORVIS for accounting. Pete November serves as CEO of Ochsner Health. Ochsner Ventures operates as the dedicated venture program of a hospital-system pension plan rather than a standalone manager. Governance links directly to Ochsner Clinic Foundation, with investment decisions aligned to the foundation's mission in patient care and research.